HOME >> MEDICINE >> NEWS
New guidelines set standard on test to diagnose acid reflux, heartburn and other diseases

New consensus guidelines will help to set the standards for physicians using esophageal manometry to accurately identify esophageal diseases such as gastroesophageal reflux disease, heartburn, problems with swallowing or non-heart related chest pain coming from the esophagus.

FINDING & IMPLICATIONS:
Although a test called esophageal manometry has provided the best diagnostic tool for healthcare professionals to diagnose suspected diseases of the esophagus, there are no uniform standards to guide physicians as to the best way to perform the procedure or to interpret the results. In fact, a lack of standardized training and multiple ways to perform the test have made it difficult or impossible to share data between physicians.

Now, new consensus guidelines will help to set the standards for physicians using esophageal manometry to accurately identify esophageal diseases such as gastroesophageal reflux disease, heartburn, problems with swallowing or non-heart related chest pain coming from the esophagus. The paper is published in the December issue of Neurogastroenterology and Motility.

"This is the first paper to provide a detailed standardized description of how esophageal manometry should be administered. It will help clinical practitioners to perform a standardized and reproducible test that can be interpreted across the board by other doctors," said Dr. Jeffrey L. Conklin, Medical Director of the Esophageal Center at Cedars-Sinai Medical Center in Los Angeles.

BACKGROUND:
The esophagus is a muscular tube that connects the throat with the stomach. Its synchronized contractions push what is swallowed into the stomach. At the upper and lower ends of the esophagus are two short areas of specialized muscle called the upper and lower esophageal sphincters. When at rest, the muscles of the upper and lower esophageal sphincters are closed and prevent anything from passing through them. For example, the upper sphincter
'"/>

Contact: Kelli Hanley
kelli.hanley@cshs.org
310-423-3674
Cedars-Sinai Medical Center
4-Dec-2003


Page: 1 2 3

Related medicine news :

1. Treatment guidelines for kids with bipolar disorder published
2. Stroke patients receive better care when hospitals get with the guidelines
3. Simpler alphabet guidelines for treating acute coronary syndrome reduce risk
4. CPR performance does not follow guidelines
5. Quality of in-hospital CPR may fail to meet guidelines
6. Study of CPR quality reveals frequent deviation from guidelines
7. PENN study emphasizes need for national guidelines for assisted reproductive technology programs
8. New treatment guidelines for pregnant women with asthma
9. New guidelines conclude all aerosol therapy devices equally effective
10. New guidelines for treating pediatric migraine released
11. Endocrine Society calls for clinical guidelines on androgens for women

Post Your Comments:
(Date:5/23/2013)... United States Vice President Dick Cheney served as the ... , In front of 1,500 guests yesterday at ... "I am delighted to be here to have the ... Year Award. I think it's a tremendous recognition; I ... company like this because there are obviously a great ...
(Date:5/23/2013)... 23, 2013 Jeanne Ettelson, president of ... its popular and only free OCD support group in ... resource for OCD sufferers, the group is lead by ... disorders. This allows group participants to learn accurate ... Response Prevention. , “Participants in Beyond OCD’s support ...
(Date:5/23/2013)... News) -- The sensation of itching is hardwired into ... a small molecule released in the spinal cord, according ... say this molecule, known as natriuretic polypeptide b (Nppb), ... system. Ultimately, this signal is experienced as an itch. ... similar, the researchers concluded that a similar process probably ...
(Date:5/23/2013)... May 23 (HealthDay News) -- Although a study ... the thinking and memory problems associated with Alzheimer,s ... have been unable to duplicate those findings. ... implications for patient safety since the drug involved ... effects, such as major blood-lipid abnormalities, pancreatitis, headaches, ...
(Date:5/23/2013)... Netsmart today announced it is ranked #49 ... technology (HIT) providers for 2013. , The HCI 100 listing ... Informatics magazine. Netsmart’s ranking of #49 is up from ... is largely due to our commitment to helping organizations forge ... resources are scarce, the demand for care is unprecedented and ...
Breaking Medicine News(10 mins):Health News:Acadian Ambulance Honors Paramedic of the Year at Annual Luncheon 2Health News:Beyond OCD Support Group Marks Fifth Anniversary 2Health News:Got an Itch? Mouse Study May Help Explain Why 2Health News:Scientists Can't Replicate Surprising Finding on Alzheimer's Treatment 2Health News:Netsmart Named to Healthcare Informatics Top 100 List 2
(Date:5/23/2013)... May 23, 2013 SynCardia Systems, Inc. ( ... FDA, Health Canada and CE ( Europe ... Glasgow Science Centre in Scotland , ... the SynCardia temporary Total Artificial Heart powered ... $3 million Bodyworks Exhibition, one of the most advanced ...
(Date:5/23/2013)... May 23, 2013 InspireMD, ... the leader in embolic protection stents, today announced ... Acute ST Elevation Reperfusion) trial demonstrating that the ... and drug eluting stents in all-cause mortality in ... from the trial were presented at the InspireMD ...
(Date:5/23/2013)... 2013  PAREXEL International Corporation (NASDAQ: PRXL ... the Jefferies Healthcare Conference in New York.  ... Financial Officer, will be making a presentation on PAREXEL ... June 3, 2013. A live webcast of ... of PAREXEL,s website at www.PAREXEL.com in the ...
Breaking Medicine Technology:Glasgow Science Centre Features SynCardia Total Artificial Heart in $3 Million Exhibition 2Glasgow Science Centre Features SynCardia Total Artificial Heart in $3 Million Exhibition 3InspireMD's MGuard Embolic Protection Stent (EPS) Shows Lower Mortality Rate in STEMI Patients at Six Months Compared to Control Group 2InspireMD's MGuard Embolic Protection Stent (EPS) Shows Lower Mortality Rate in STEMI Patients at Six Months Compared to Control Group 3InspireMD's MGuard Embolic Protection Stent (EPS) Shows Lower Mortality Rate in STEMI Patients at Six Months Compared to Control Group 4InspireMD's MGuard Embolic Protection Stent (EPS) Shows Lower Mortality Rate in STEMI Patients at Six Months Compared to Control Group 5PAREXEL International To Present At Jefferies Healthcare Conference 2
Cached News: